The role of dopamine in perception

The role of dopamine in perception - DA and perception

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON46867

Enrollment

Registered

2018-03-19

Start date

2018-01-02

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

geen aandoening. Onderzoek betreft de werking van dopamine in het gezonde brein. NA

Interventions

Subjects will receive 1.5 mg cabergoline or placebo on two different test sessions in a randomized order.

cognition

dopamine

neuroscience

perception

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Healthy volunteers between 18 and 30 years old Native Dutch speakers Predominant right-handedness BMI between 18.5 and 30 Use of hormonal contraceptives (female participants only)

Exclusion criteria

Exclusion criteria: Current or history of any medical or psychiatric disorder or disease Abnormal bloodpressure or heart rate;For complete overview of the exclusion criteria, see C1

Design outcomes

Primary

Measure	Time frame
Primary study parameters will include task performance (e.g. accuracy, reaction times), electroencephalographic (EEG) measures and functional magnetic resonance imaging (fMRI) measures.	—

Secondary

Measure	Time frame
Measures of baseline spontaneous eye blink rate	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)